levodopa/carbidopa
Showing 1 - 25 of 494
Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,
Not yet recruiting
- Idiopathic Parkinson Disease
- levodopa/carbidopa oral formulation A
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Jul 20, 2022
Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)
Enrolling by invitation
- Parkinson Disease
- Treatment Adherence
-
Ankara, TurkeyAnkara Atatürk Sanatorium Training and Research Hospital
Oct 30, 2023
Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)
Completed
- Parkinson Disease
- Standard LD/CD
- Semi continuous intra-oral administration of LD/CD
-
Rome, ItalyIrccs San Raffaele Pisana
Oct 17, 2022
Parkinson Disease Trial in Mansoura (levodopa-carbidopa, Montelukast)
Not yet recruiting
- Parkinson Disease
-
Mansoura, EgyptFaculty of Medicine, Mansoura University
Oct 28, 2023
Healthy Trial (Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets
Not yet recruiting
- Healthy
- Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)
- (no location specified)
Jul 26, 2023
Parkinson's Disease Trial in Amsterdam (Continuous intrajejunal infusion of levodopa-carbidopa, deep brain stimulation)
Active, not recruiting
- Parkinson's Disease
- Continuous intrajejunal infusion of levodopa-carbidopa
- deep brain stimulation
-
Amsterdam, Noord Holland, NetherlandsAcademic Medical Center
Apr 20, 2022
Depression Trial in Atlanta (Levodopa+carbidopa, Placebo)
Completed
- Depression
- Levodopa+carbidopa
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Aug 24, 2022
Spinal Cord Injuries, Drug Effect Trial in Lausanne (Buspirone, Levodopa-Carbidopa, Buspirone + Levodopa-Carbidopa)
Enrolling by invitation
- Spinal Cord Injuries
- Drug Effect
- Buspirone
- +3 more
-
Lausanne, Vaud, SwitzerlandCHUV
May 25, 2022
Small Intestine and Blood Fingerprint Study in Parkinson's
Not yet recruiting
- Parkinson Disease
- Fluid biopsy capsule
- Levodopa-Carbidopa Immediate Release
-
Calgary, Alberta, CanadaUniversity of Calgary
Aug 15, 2023
Advanced Parkinson's Disease Trial (Levodopa-Carbidopa Intestinal Gel, Percutaneous Endoscopic Gastrostomy with Jejunal
Completed
- Advanced Parkinson's Disease
- Levodopa-Carbidopa Intestinal Gel
- +2 more
- (no location specified)
Jul 14, 2021
Stroke Trial in Charlestown (Placebo, Levodopa / Carbidopa, Armeo)
Withdrawn
- Stroke
- Placebo
- +2 more
-
Charlestown, MassachusettsSpaulding Rehabilitation Hospital
Dec 17, 2021
Parkinson Disease Trial in Tanta (levodopa-carbidopa, Metformin)
Not yet recruiting
- Parkinson Disease
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 11, 2023
Bioequivalence Trial in Chennai (Levodopa 250mg and Carbidopa 25mg Test Drug tablet, Levodopa 250mg and Carbidopa 25mg Referent
Completed
- Bioequivalence
- Levodopa 250mg and Carbidopa 25mg Test Drug tablet
- Levodopa 250mg and Carbidopa 25mg Referent Product tablet
-
Chennai, Tamil Nadu, IndiaAzidus Laboratories Ltd.
Mar 7, 2022
Chronic Pain Trial in Rochester (Methylphenidate, carbidopa-levodopa, Placebo)
Recruiting
- Chronic Pain
- Methylphenidate
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center
Jan 9, 2023
Parkinson Disease Trial in Ahmedabad (WD-1603 Carbidopa-Levodopa Extended-Release Tablets)
Recruiting
- Parkinson Disease
- WD-1603 Carbidopa-Levodopa Extended-Release Tablets
-
Ahmedabad, Gujarat, IndiaLambda Therapeutic Research Ltd.
Nov 10, 2021
Parkinson Disease Trial in Cleveland (Neurostimulation, Carbidopa 25/Levodopa 100Mg Tab)
Recruiting
- Parkinson Disease
- Neurostimulation
- Carbidopa 25/Levodopa 100Mg Tab
-
Cleveland, OhioCleveland Clinic
Aug 25, 2023
Parkinson's Disease Trial in Worldwide (ND0612 (Levodopa/Carbidopa solution), ND0612 (Levodopa/Carbidopa solution) + morning
Completed
- Parkinson's Disease
- ND0612 (Levodopa/Carbidopa solution)
- ND0612 (Levodopa/Carbidopa solution) + morning oral IR-LD/CD
-
Chicago, Illinois
- +10 more
Feb 16, 2022
Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)
Completed
- Impulse Control Disorder
- Levodopa/Carbidopa(200mg/50mg)
- Dopaminergic Agonists
-
Anyang, Korea, Republic of
- +4 more
Mar 9, 2021
Parkinson Disease Trial in Shanghai (WD-1603 Carbidopa-Levodopa Extended-Release Tablets, Placebo)
Recruiting
- Parkinson Disease
- WD-1603 Carbidopa-Levodopa Extended-Release Tablets
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Huashan Hospital
Oct 28, 2021
Anhedonia, Depression Trial in Atlanta (Carbidopa Levodopa, Placebo)
Not yet recruiting
- Anhedonia
- Depression
- Carbidopa Levodopa
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Oct 4, 2023
Healthy Volunteers Trial in Neu-Ulm (Levodopa, Carbidopa, ODM-104)
Advanced Parkinson's Disease Trial in Worldwide (Optimized Medical Treatment, Levodopa-Carbidopa Intestinal Gel, Nasojejunal
Completed
- Advanced Parkinson's Disease
- Optimized Medical Treatment
- +3 more
-
Fountain Valley, California
- +37 more
Nov 19, 2022
Parkinson's Disease Trial in Saint Louis (Levodopa)
Completed
- Parkinson's Disease
-
Saint Louis, MissouriWashington University School of Medicine, Movement Disorders Cen
Oct 12, 2022
Assess Participant/Caregiver/Investigator Satisfaction of
Completed
- Parkinson's Disease
-
Herston, Queensland, Australia
- +12 more
Jan 31, 2023
Parkinson's Disease Trial in Italy, Luxembourg, Spain (continuous oral delivery of levodopa/carbidopa)
Recruiting
- Parkinson's Disease
- continuous oral delivery of levodopa/carbidopa
-
Cassino, Italy
- +3 more
Jul 20, 2021